- Home
- PROK vs CHN Comparison
PROK vs CHN Comparison
Compare PROK & CHN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- CHN
- Stock Information
- Founded
- PROK 2015
- CHN 1992
- Country
- PROK United States
- CHN United States
- Employees
- PROK N/A
- CHN N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- CHN Investment Managers
- Sector
- PROK Health Care
- CHN Finance
- Exchange
- PROK Nasdaq
- CHN Nasdaq
- Market Cap
- PROK 126.8M
- CHN 128.4M
- IPO Year
- PROK N/A
- CHN N/A
- Fundamental
- Price
- PROK $0.84
- CHN $12.75
- Analyst Decision
- PROK Buy
- CHN
- Analyst Count
- PROK 4
- CHN 0
- Target Price
- PROK $5.00
- CHN N/A
- AVG Volume (30 Days)
- PROK 434.6K
- CHN 31.8K
- Earning Date
- PROK 05-09-2025
- CHN 01-01-0001
- Dividend Yield
- PROK N/A
- CHN 0.19%
- EPS Growth
- PROK N/A
- CHN N/A
- EPS
- PROK N/A
- CHN N/A
- Revenue
- PROK $76,000.00
- CHN N/A
- Revenue This Year
- PROK N/A
- CHN N/A
- Revenue Next Year
- PROK N/A
- CHN N/A
- P/E Ratio
- PROK N/A
- CHN N/A
- Revenue Growth
- PROK N/A
- CHN N/A
- 52 Week Low
- PROK $0.80
- CHN $9.00
- 52 Week High
- PROK $4.44
- CHN $12.98
- Technical
- Relative Strength Index (RSI)
- PROK 29.40
- CHN 43.27
- Support Level
- PROK $0.87
- CHN $13.00
- Resistance Level
- PROK $1.00
- CHN $13.30
- Average True Range (ATR)
- PROK 0.10
- CHN 0.25
- MACD
- PROK 0.01
- CHN -0.12
- Stochastic Oscillator
- PROK 14.70
- CHN 5.00
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.
About CHN China Fund Inc. (The)
CHINA FUND INC is a non-diversified, closed-end management investment company. Its investment objective is a long-term capital appreciation which it seeks to achieve by investing in equity securities with trading in China and outside China. It invests in various industries such as Insurance, Entertainment, Machinery, Electrical Equipment, Beverages, Hotels, Restaurants, and Leisure among others.